See All Slides - tctmd.com

Slides

Presentation TCT 2013

Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety

Presenter: Lian R. Gao

October 29, 2013

Presentation TCT 2013

Sutureless Surgical Aortic Valves. Any Role in the TAVR Era?

Presenter: Rudiger Lange

October 29, 2013

Presentation TCT 2013

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

Presenter: Fumiyuki Otsuka

October 29, 2013

Presentation TCT 2013

Case Presentation #1: Out-of-Hospital Cardiac Arrest Presenting with Cardiogenic Shock

Presenter: Andreas Baumbach

October 29, 2013

Presentation TCT 2013

When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist

Presenter: Ulrich Jorde

October 29, 2013

Presentation TCT 2013

Do We Need a Trial of FFR-Guided Surgical Revascularization? The CTSN Network Proposal

Presenter: Michael Argenziano

October 29, 2013

Presentation TCT 2013

Hybrid Therapy: The Best of Both Worlds (and Considerations for a CTSN-Sponsored Randomized Trial)

Presenter: John Puskas

October 29, 2013

Presentation TCT 2013

Case Presentation and Topic Review: An HCM Patient Three Years After Septal Ablation - What Follow-up Is Needed?

Presenter: Paul Sorajja

October 29, 2013

Presentation TCT 2013

Prognostic Impact of Non-Infarct-Related-Artery Chronic Total Occlusion Revascularization in Patients with Acute Myocardial Infarction Treated by Primary Angioplasty

Presenter: Renato Valenti

October 29, 2013

Presentation TCT 2013

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Presenter: Larry Wood

October 29, 2013

Advertisement

Slides

Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety

Sutureless Surgical Aortic Valves. Any Role in the TAVR Era?

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

Case Presentation #1: Out-of-Hospital Cardiac Arrest Presenting with Cardiogenic Shock

When and How Should We Treat Functional MR? Perspective from a Heart Failure Specialist

Do We Need a Trial of FFR-Guided Surgical Revascularization? The CTSN Network Proposal

Hybrid Therapy: The Best of Both Worlds (and Considerations for a CTSN-Sponsored Randomized Trial)

Case Presentation and Topic Review: An HCM Patient Three Years After Septal Ablation - What Follow-up Is Needed?

Prognostic Impact of Non-Infarct-Related-Artery Chronic Total Occlusion Revascularization in Patients with Acute Myocardial Infarction Treated by Primary Angioplasty

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content